PCP pools the efforts of several public procurers in procuring R&D services which enables  public procurers access to new products and services. By sharing risks and benefits with suppliers, optimum conditions are met for wide commercialization and take-up of R&D results.




PPI refers to procurement where contracting authorities act as a launching customer(early adopter) to purchase/deploy innovative goods or services that are newly arriving on the market and which are not yet available on a large-scale commercial basis.




1.Analysis of Innovation Procurement practices 

This document provides a  systematized analysis of current State of Art in Innovation Procurement in the EU and of relevant innovation procurement cases from different Member States. The case studies can be found published in their totality on here.

The aim is to understand and illustrate what are the challenges to be faced and the benefits to be achieved when implementing (in a proper way) PCP and PPI in Health sector (eHealth, Active Aging and Independent Living).

2. PCP/ PPI Toolkit

This guide aim is to introduce relevant aspects when procuring innovation and the kind of problems that a careful procurement design and management can solve.  It provides real-life examples on “how” to assess the need, to dialogue with  the market,  to define a business case and  to design the competitive procedure.

3. PCP/ PPI Gap Analysis and Recommendations

This document provides evidence and analysis of the current gap in the adoption of the Pre-Commercial Public Procurement (PCP) and Procurement of Innovative Solutions (PPI) across the INSPIRE partner countries and European healthcare service systems. These findings have been validated and discussed via workshop sessions held in Helsinki, Vienna, Barcelona and London. A number of recommendations are made in this document to enforce the procurer’s and innovation policy makers’ awareness in the PCP & PPI and stimulate actions at different level of governance.

The INSPIRE observations indicate that public authorities may not be yet prepared to set up a PCP&PPI strategy, either because they are not fully aware of its rationale or because they lack proper roles, mandates, skills, resources and metrics to implement it.

4. The Business case modelling

This document is intended to indicate the key questions which Public Procurers and their organisations will need to be able to answer in order to establish whether they should or should not conduct the future-focused procurement methodology known as Pre-Commercial Procurement (PCP). It will explain why the selected questions are important and provide some guidance as to how answers to the questions can be found.

5. The Investor engagement in PCP

This document provides an analysis of the current levels of awareness and interest by investors of the Pre-Commercial Procurement (PCP) initiatives across the EU healthcare Research and Development markets. It also offers recommendations on how to develop this interest and activities further.

No Events
Do you want to contact with PCP/PI expert? Any specific question?